iMDx to Participate in NYC Investment Conferences September 8 - 11

iMDx (NASDAQ:IMDX) announced its participation in two upcoming investor conferences in New York City.

Rhea-AI Summary

iMDx (NASDAQ:IMDX) announced its participation in two upcoming investor conferences in New York City. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-9, 2025, featuring a company presentation on September 8 at 5:00 pm ET, along with one-on-one meetings.

Additionally, iMDx will participate in the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, 2025, which will consist of one-on-one meetings with investors at the Yale Club of New York City.

[]

Argus Aug 27 session

-1.20% close to close Open Argus

Details

News Market Reaction – IMDX

On Aug 27, the first trading day after this news, IMDX closed 1.20% below the previous close.

Data tracked by StockTitan Argus for the Aug 27 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can be found below:

Event: H.C. Wainwright 27^th Annual Global Investment Conference
Date: September 8 – 9, 2025
Location: In-person at the Lotte New York Palace Hotel and virtual
Format: Company presentation on Monday, September 8 at 5:00 pm ET, and one-on-one meetings
Link to live and replay: Click here

Event: Lake Street Capital Markets 9th Annual Best Ideas Growth Conference (BIG9)
Date: September 11, 2025
Location: In-person at the Yale Club of New York City
Format: One-on-one meetings

Investors wishing to participate are encouraged to reach out to their H.C. Wainwright or Lake Street sales representatives.

About Insight Molecular Diagnostics, Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.Insight Molecular Diagnostics.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact: 

Doug Farrell 
LifeSci Advisors LLC 
dfarrell@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is iMDx presenting at the H.C. Wainwright Global Investment Conference 2025?

iMDx will present on Monday, September 8, 2025, at 5:00 pm ET at the Lotte New York Palace Hotel.

Where will the Lake Street Capital Markets BIG9 Conference for iMDx take place?

The Lake Street Capital Markets conference will take place in-person at the Yale Club of New York City on September 11, 2025.

How can investors participate in meetings with iMDx at these conferences?

Investors should contact their H.C. Wainwright or Lake Street sales representatives to arrange participation in one-on-one meetings.

What format will iMDx's participation take at these investment conferences?

At H.C. Wainwright, iMDx will deliver a company presentation and hold one-on-one meetings. At Lake Street's conference, the format will be one-on-one meetings only.